Drawing for BIOARMOUR

USPTO serial 98239424

BIOARMOUR

Reviewed by CopyMark Law Group

Status 814Office Action
Filing date
Status date
Registration date
—
Examiner
DAVIS, ALEXIS A
Law office
TMEG LAW OFFICE 101

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Need help with BIOARMOUR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John J Davis

John J Davis Kearney, McWilliams & Davis, PLLC55 Waugh #150Houston, TX 77007United States

Goods and services

ClassDescriptionStatusFirst use
009Data processors incorporating bio-sensors being sensors for detecting biological data; biochips for research or scientific purposes; wearable personal electronic fitness activity monitoring device, not for medical use, to measure and record changes in heart rate, changes in blood pressure, time changes, speed changes and acceleration changes; wearable computer hardware device for measuring physiological and biological data, not for medical use; downloadable bioinformatics software for storing and analyzing biological data; downloadable computer software for measuring, recording, and analyzing vital signs, heart rate, and heart signals; downloadable computer application software for measuring, tracking, analyzing, displaying, uploading, and transmitting data from wearable electronic devices and portable/wearable electronic devices being smart watches; downloadable software for remote monitoring of cardiac patients; downloadable computer software used with electrocardiographic apparatus and instruments for reading electrocardiographic apparatus and instruments; downloadable computer software for analysing electrocardiogram (ECG) data; battery charge devices; downloadable computer application software for monitoring electrocardiograms (ECG) for use on mobile phones; downloadable computer software for measuring electrocardiogram (ECG) data; downloadable software for measuring, analyzing and transmitting patients' electrocardiogram (ECG) data to medical doctors, nurses and staff all via wearable electrocardiogram (ECG) measuring devices; downloadable computer software for recording, organizing and storing medical data; downloadable computer software for diagnosing diseases for medical purposes; downloadable software using artificial intelligence for analysis of electrocardiogram (ECG) data; downloadable computer application software for mobile phones for measuring, tracking, analysing, displaying, uploading, transmission of data from wearable electronic devices and portable and wearable electronic devices being mobile phones; downloadable computer software for analyzing heart rate data for use in healthcare; downloadable software that automatically transmits patients' health input data and artificial intelligence (AI) based algorithm health analysis data to medical doctors, nurses and staffACTIVESep 24, 2024
010Heart rate monitoring medical apparatus; heartbeat measuring apparatus; heart rate monitoring apparatus; electrocardiogram (ECG) measuring devices in the nature of medical devices for measuring vital signs via electrocardiogram (ECG) signals; wearable medical patches for measuring electrocardiogram (ECG) signals, namely, medical bioelectronic devices being bioelectrochemical biosensors; medical electrode patches for measuring electrocardiogram (ECG) signals, namely, cardiac electrodes; wearable medical devices for monitoring electrocardiogram (ECG) signals, namely, heart monitors; wearable devices for measuring electrocardiogram (ECG) signals for medical purposes, namely, biosensors in the nature of heart monitors for measuring cardiac human health data; wearable medical electrode patches for measuring electrocardiogram (ECG) signals, namely, cardiac electrodes; wireless biometric data signal measuring devices in the nature of wearable torso monitors for medical use; biometric data measuring devices in the nature of wearable heart monitors for medical purposes; diagnostic apparatus for medical purposes, namely, pulse oximeters, stethoscopes, and clinical thermometers; measuring instruments for medical purposes, namely, meters for measuring pulse, thermometers for medical use, and motion testing apparatus for physical rehabilitation; medical apparatus for diagnosing suspected heart attacks; medical diagnostic apparatus and instruments in the nature of wearable monitors used to measure biometric data for medical use using with embedded artificial intelligence software for predicting heart health; diagnostic apparatus and instruments for medical purposes, namely, arterial blood pressure measuring apparatus and instruments, heartbeat measuring apparatus and instruments, and patient sensors for measuring blood properties and respiratory events; in vitro diagnostic devices for medical purposes in the nature of biosensors for detecting infectious diseases; medical apparatus for analysing measured physical vital signals in the bodyACTIVESep 24, 2024

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 9, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 9, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 9, 2026ALIEASSIGNED TO LIE—
Oct 7, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 8, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Jul 8, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Apr 24, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 24, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 24, 2026CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 7, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Oct 20, 2025IUAFUSE AMENDMENT FILED—
Oct 20, 2025EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Oct 9, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 8, 2025EX1GSOU EXTENSION 1 GRANTED—
Oct 8, 2025EXT1SOU EXTENSION 1 FILED—
Oct 8, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 6, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 11, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 11, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 5, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 13, 2025ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Feb 7, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 17, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 17, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 17, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 13, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 13, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Dec 13, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 13, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 13, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Dec 13, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 12, 2024XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Sep 12, 2024XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Aug 7, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 7, 2024EWORTEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED—
Aug 7, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 7, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 25, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 25, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jul 25, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 25, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 18, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 18, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 18, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 6, 2024DOCKASSIGNED TO EXAMINER—
Oct 31, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 28, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance